Status:
COMPLETED
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Lupus Nephritis
Eligibility:
All Genders
Brief Summary
To evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use.
Detailed Description
The objectives of the survey are to evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use situations, and to identify factors that might affect the safety and efficacy of...
Eligibility Criteria
Inclusion
- patients receiving tacrolimus for the treatment of lupus nephritis
Exclusion
Key Trial Info
Start Date :
April 10 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
1484 Patients enrolled
Trial Details
Trial ID
NCT01410747
Start Date
April 10 2007
End Date
January 31 2020
Last Update
October 22 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chūbu, Japan
2
Hokkaido, Japan
3
Kansai, Japan
4
Kantou, Japan